MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM FDA approval date

The FDA approved MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM on 22 Dec 2025.

FDA approval date
22 Dec 2025

Drug identity has not yet been verified against registry records

Also recorded as DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-12-22DayMUCINEX 12HR COLD & FEVER MULTI-SYMPTOMFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217338", "applicant_as_listed_by_fda": "RECKITT BENCKISER", "brand_names": ["MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM"], "active_ingredients": ["DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "NAPROXEN SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251222", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026